Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
Heterozygous mutations in the genes encoding the proα1(I) or proα2(I) chains of type I procollagen (COL1A1 and COL1A2, respectively) account for most cases of osteogenesis imperfecta (OI), a disorder characterized by reduced bone strength and increased fracture risk.
|
28436160 |
2017 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
Mutations in COL1A1 and COL1A2 and dental aberrations in children and adolescents with osteogenesis imperfecta - A retrospective cohort study.
|
28498836 |
2017 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Confirmation of the pathogenicity of a mutation p.G337C in the COL1A2 gene associated with osteogenesis imperfecta.
|
28953610 |
2017 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
It has been known for three decades that the majority of individuals with OI have mutations in COL1A1 or COL1A2, the two genes coding for collagen type I alpha chains, but in the past 10 years defects in at least 17 other genes have been linked to OI.
|
27492436 |
2016 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in COL1A2 are known to cause the autosomal dominant disorder osteogenesis imperfecta.
|
26235824 |
2016 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The mutations p.Gly257Arg, p.Gly767Ser and p.Gly821Ser in COL1A1 and p.Gly337Ser in COL1A2 may be located at a mutation hotspot for human OI due to the high repetition rate in OI patients.
|
27748872 |
2016 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta.
|
27519266 |
2016 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This is the first report of a copy-neutral structural variant involving COL1A2 that leads to a rare type of OI.
|
27312322 |
2016 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Further genotype analysis excluded types of osteogenesis imperfecta associated with mutations in the COL1A1 and COL1A2 genes.
|
28222408 |
2016 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Most cases of osteogenesis imperfecta (OI) are caused by heterozygous mutations in COL1A1 or COL1A2, the genes encoding the two type I procollagen alpha chains, proα1 (I) and proα2 (I).
|
25858481 |
2015 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Approximately 90% of individuals with OI are heterozygous for mutations in the COL1A1 and COL1A2 genes, with dominant pattern of inheritance or sporadic mutations.
|
25046257 |
2015 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
We used an array including ALPL gene, genes of differential diagnosis COL1A1 and COL1A2 that represent 90% of OI cases, SOX9, responsible for CD, and 8 potentially modifier genes of HPP.
|
26432670 |
2015 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The provided diagnoses included osteogenesis imperfecta II (COL1A2), glycogen storage disease IV (GBE1), oral-facial-digital syndrome 1 (OFD1), and RAPSN-associated fetal akinesia deformation sequence.
|
26147564 |
2015 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
We briefly compare reported phenotypes for patients with missense variants in the C-propeptide domain for other human collagen disorders including COL1A1 and COL1A2 (osteogenesis imperfecta).
|
25846194 |
2015 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The majority of Osteogenesis Imperfecta (OI) cases are caused by mutations in one of the two genes, COL1A1 and COL1A2 encoding for the two chains that trimerize to form the procollagen 1 molecule.
|
24767406 |
2014 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI), or brittle bone disease, is most often caused by dominant mutations in the collagen I genes COL1A1/COL1A2, whereas rarer recessive OI is often caused by mutations in genes encoding collagen I-interacting proteins.
|
24419319 |
2014 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutation spectrum of COL1A1 and COL1A2 genes in Indian patients with osteogenesis imperfecta.
|
24668929 |
2014 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Dominantly inherited COL1A1 or COL1A2 mutations appear to be causative in the majority of OI types, but rare recessively inherited genes have also been reported.
|
23853499 |
2013 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
Therefore the predicted COL1A2 propeptide lacks the last 13 C-terminal amino acids, suggesting that the OI phenotype results from decelerated assembly and overmodification of the collagen triple helix.
|
24140640 |
2013 |
Osteogenesis Imperfecta
|
0.700 |
Biomarker
|
disease |
BEFREE |
To identify the cause of OI in eight children with severe bone fragility and a clinical diagnosis of OI type IV who had had negative results on COL1A1/COL1A2 Sanger sequencing.
|
23434763 |
2013 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
More than 90% of people who have osteogenesis imperfecta (OI) have heterozygous mutations in one of the two type I collagen genes, COL1A1 and COL1A2.
|
23145505 |
2012 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta (OI) is an inherited connective tissue disorder with skeletal dysplasia of varying severity, predominantly caused by mutations in the collagen I genes (COL1A1/COL1A2).
|
22589248 |
2012 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
About 90% of individuals with OI are heterozygous for causative variants in the COL1A1 and COL1A2 genes.
|
21829228 |
2012 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Osteogenesis imperfecta murine (Oim) mice, with a mutation in Col1a2, have distal leaflet thickening and increased proteoglycan composition characteristic of myxomatous valve disease.
|
22248532 |
2012 |
Osteogenesis Imperfecta
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Validation of a quantitative PCR-high-resolution melting protocol for simultaneous screening of COL1A1 and COL1A2 point mutations and large rearrangements: application for diagnosis of osteogenesis imperfecta.
|
22753364 |
2012 |